Heterologous boosting with recombinant VSV-846 in BCG-primed mice confers improved protection against Mycobacterium infection
Tuberculosis (TB) remains a major health problem worldwide, and the development of effective vaccines is urgently needed. Vaccination strategies based on heterologous prime–boost protocols using Mycobacterium bovis bacillus Calmette-Guérin (BCG) as primer and modified vaccinia virus Ankara strain ex...
Na minha lista:
| Principais autores: | , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Taylor & Francis Group
2017-04-01
|
| Serier: | Human Vaccines & Immunotherapeutics |
| Fag: | |
| Online adgang: | http://dx.doi.org/10.1080/21645515.2016.1261229 |
| Tags: |
Ingen Tags, Vær først til at tagge denne postø!
|